Financial statements F1 Pharma
Balance sheet of F1 Pharma
Company age:
Age:
6 y. 4 m. 2 d.
Share capital:
Share capital:
1 669 800 PLN
Balance sheet data of F1 PHARMA
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 1 392 280,91 | 1 526 006,12 | 1 324 202,77 | 825 638,79 | 1 096 607,14 |
| A. Fixed assets | 549 601,46 | 360 651,20 | 185 334,61 | 10 080,67 | 4 790,19 |
| B. Current assets | 842 679,45 | 1 165 354,92 | 1 138 868,16 | 815 558,12 | 1 091 816,95 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 392 280,91 | 1 526 006,12 | 1 324 202,77 | 825 638,79 | 1 096 607,14 |
| A. Equity | 613 918,63 | 653 234,69 | 609 720,91 | 360 633,86 | 343 145,57 |
| B. Liabilities and provisions for liabilities | 778 362,28 | 872 771,43 | 714 481,86 | 465 004,93 | 753 461,57 |
| I. Long-term liabilities | 0,00 | 76 750,36 | 25 381,75 | 0,00 | 0,00 |
| II. Short-term liabilities | 684 371,65 | 702 030,44 | 593 794,46 | 226 920,11 | 472 003,74 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.